Cargando…
Personalized cancer neoantigen vaccines come of age
Cancer vaccines have encountered their ideal personalized partner along with evidence for great breakthroughs in the identification and synthesis of neoantigens. Individual cancer neoantigen vaccines are capable of eliciting robust T-cell responses and have been demonstrated to achieve striking clin...
Autores principales: | Chu, Yanhong, Liu, Qin, Wei, Jia, Liu, Baorui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6096398/ https://www.ncbi.nlm.nih.gov/pubmed/30128050 http://dx.doi.org/10.7150/thno.24387 |
Ejemplares similares
-
Personalized neoantigen vaccination with synthetic long peptides: recent advances and future perspectives
por: Chen, Xiaotong, et al.
Publicado: (2020) -
Engineering neoantigen vaccines to improve cancer personalized immunotherapy
por: Liu, Zaoqu, et al.
Publicado: (2022) -
Benefits of an Immunogenic Personalized Neoantigen Nanovaccine in Patients with High‐Risk Gastric/Gastroesophageal Junction Cancer
por: Liu, Qin, et al.
Publicado: (2022) -
Recent advances in neoantigen vaccines for treating non‐small cell lung cancer
por: Su, Shu, et al.
Publicado: (2023) -
Benefits of an Immunogenic Personalized Neoantigen Nanovaccine in Patients with High‐Risk Gastric/Gastroesophageal Junction Cancer (Adv. Sci. 1/2023)
por: Liu, Qin, et al.
Publicado: (2023)